本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Conduit Pharmaceuticals Inc.

2.92
+0.12004.29%
盘后2.92-0.0017-0.06%16:50 EDT
成交量:16.43万
成交额:46.95万
市值:278.04万
市盈率:-0.01
高:2.93
开:2.76
低:2.67
收:2.80
数据加载中...
2023/10/17

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/10/06

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/29

重要事件披露

Form 8-K - Current report
2023/09/29

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/22

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/09/21

重要事件披露

Form 8-K - Current report
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/09/07

重要事件披露

Form 8-K - Current report
2023/09/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/31

重要事件披露

Form 8-K - Current report
2023/08/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/23

重要事件披露

Form 8-K - Current report
2023/08/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/16

重要事件披露

Form 8-K - Current report
2023/08/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]